Respiratory System Agents
"Respiratory System Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used for their effects on the respiratory system.
| Descriptor ID |
D019141
|
| MeSH Number(s) |
D27.505.954.796
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory System Agents".
Below are MeSH descriptors whose meaning is more specific than "Respiratory System Agents".
This graph shows the total number of publications written about "Respiratory System Agents" by people in this website by year, and whether "Respiratory System Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 2 | 2 |
| 2018 | 5 | 3 | 8 |
| 2019 | 1 | 1 | 2 |
| 2020 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Respiratory System Agents" by people in Profiles.
-
Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study. Crit Care Med. 2021 02 01; 49(2):e191-e198.
-
Peptides: Prospects for Use in the Treatment of COVID-19. Molecules. 2020 Sep 24; 25(19).
-
Aerosol Treatments During COVID-19 Pandemic: A Personal Journey. J Aerosol Med Pulm Drug Deliv. 2020 10; 33(5):288-289.
-
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? Anaesth Crit Care Pain Med. 2020 08; 39(4):451-452.
-
Use of aerosolised medications at home for COVID-19. Lancet Respir Med. 2020 08; 8(8):754-756.
-
Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med. 2020 06 16; 26(1):58.
-
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome. Chest. 2020 11; 158(5):2003-2006.
-
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome. Anaesth Crit Care Pain Med. 2020 08; 39(4):471-472.
-
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients. Anaesth Crit Care Pain Med. 2020 08; 39(4):467-469.
-
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. 2020 05; 46(3):306-308.